anmelden
OMX Nordic 40
2.718,06
PKT
+10,11
PKT
+0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.11.24 | AstraZeneca Neutral | UBS AG | |
| 19.11.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 19.11.24 | Volvo (B) Neutral | UBS AG | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
| 13.11.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
| 07.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Novo Nordisk Halten | DZ BANK | |
| 07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. |
